Horizon Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,190

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $27.8B

Horizon Therapeutics General Information

Description

Developer of drug therapies intended to deliver medicines for rare, autoimmune, and severe inflammatory diseases. The company is focused on discovering, developing, and commercializing medicines to address the needs of people impacted by rare, autoimmune, and severe inflammatory diseases, enabling medical staff to supply critical medicine for treating autoimmune diseases.

Contact Information

Formerly Known As
Horizon Pharma
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 70 Saint Stephens Green
  • Saint Kevin's
  • Dublin D02 E2X4
  • Ireland
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 70 Saint Stephens Green
  • Saint Kevin's
  • Dublin D02 E2X4
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Horizon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Merger/Acquisition 06-Oct-2023 $27.8B Completed Profitable
18. Debt - Acquisition 26-Feb-2021 Completed Generating Revenue
17. Debt Refinancing 16-Dec-2019 Completed Generating Revenue
16. Debt Refinancing 11-Jul-2019 Completed Generating Revenue
15. Debt Refinancing 17-May-2019 Completed Generating Revenue
14. Debt Refinancing 17-Oct-2018 Completed Generating Revenue
13. Debt Refinancing 17-Oct-2017 Completed Generating Revenue
12. Debt Refinancing 23-Mar-2017 Completed Generating Revenue
11. Debt - Acquisition 13-Oct-2016 $675M $1.75B Completed Generating Revenue
10. Merger/Acquisition 27-Jun-2016 Cancelled Generating Revenue
To view Horizon Therapeutics’s complete valuation and funding history, request access »

Horizon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug therapies intended to deliver medicines for rare, autoimmune, and severe inflammatory diseases. The co
Drug Discovery
Dublin, Ireland
2,190 As of 2023

Pratteln, Switzerland
 

Rahway, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Horizon Therapeutics Competitors (59)

One of Horizon Therapeutics’s 59 competitors is Santhera Pharmaceuticals Holding, a Formerly VC-backed company based in Pratteln, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Santhera Pharmaceuticals Holding Formerly VC-backed Pratteln, Switzerland
Merck & Co. Corporation Rahway, NJ
Crinetics Pharmaceuticals Formerly VC-backed San Diego, CA
Arcturus Therapeutics Holdings Formerly VC-backed San Diego, CA
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 5 of 59 competitors. Get the full list »

Horizon Therapeutics Patents

Horizon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026125220-A Disaster-response life vest Pending 22-Jan-2025
JP-2026086834-A Aroma management system Pending 16-Jun-2022
JP-7598522-B2 Aroma management system Active 16-Jun-2022
AU-2021324665-A1 Methods of treating gout Active 10-Aug-2020
AU-2021324665-B2 Methods of treating gout Active 10-Aug-2020 A61K47/60
To view Horizon Therapeutics’s complete patent history, request access »

Horizon Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Horizon Therapeutics Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Athyrium Capital Management Asset Manager Minority
Atlas Venture Venture Capital Minority
Avoro Capital Venture Capital Minority
Deerfield Management Venture Capital Minority
Deutsche Bank Investment Bank Minority
You’re viewing 5 of 17 investors. Get the full list »

Horizon Therapeutics Investments & Acquisitions (13)

Horizon Therapeutics’s most recent deal was a Corporate Asset Purchase with EirGen Pharma (Drug Product Manufacturing Facility in Waterford, Ireland) for . The deal was made on 01-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EirGen Pharma (Drug Product Manufacturing Facility in Waterford, Ireland) 01-Jul-2021 Corporate Asset Purchase Buildings and Property
Viela Bio 15-Mar-2021 Merger/Acquisition Drug Discovery
Curzion Pharmaceuticals 01-Apr-2020 Merger/Acquisition Biotechnology
Straight (Distributors (Healthcare)) 26-Nov-2019 Merger/Acquisition Distributors (Healthcare)
River Vision 08-May-2017 Merger/Acquisition Biotechnology
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Horizon Therapeutics ESG

Risk Overview

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Horizon Therapeutics’s complete esg history, request access »

Horizon Therapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Straight (Distributors (Healthcare)) Vemars, France 2018

Horizon Therapeutics FAQs

  • When was Horizon Therapeutics founded?

    Horizon Therapeutics was founded in 2008.

  • Where is Horizon Therapeutics headquartered?

    Horizon Therapeutics is headquartered in Dublin, Ireland.

  • What is the size of Horizon Therapeutics?

    Horizon Therapeutics has 2,190 total employees.

  • What industry is Horizon Therapeutics in?

    Horizon Therapeutics’s primary industry is Drug Discovery.

  • Is Horizon Therapeutics a private or public company?

    Horizon Therapeutics is a Private company.

  • What is the current valuation of Horizon Therapeutics?

    The current valuation of Horizon Therapeutics is .

  • What is Horizon Therapeutics’s current revenue?

    The current revenue for Horizon Therapeutics is .

  • How much funding has Horizon Therapeutics raised over time?

    Horizon Therapeutics has raised $4.8B.

  • Who are Horizon Therapeutics’s investors?

    Athyrium Capital Management, Atlas Venture, Avoro Capital, Deerfield Management, and Deutsche Bank are 5 of 17 investors who have invested in Horizon Therapeutics.

  • Who are Horizon Therapeutics’s competitors?

    Santhera Pharmaceuticals Holding, Merck & Co., Crinetics Pharmaceuticals, Arcturus Therapeutics Holdings, and ACADIA Pharmaceuticals are some of the 59 competitors of Horizon Therapeutics.

  • When was Horizon Therapeutics acquired?

    Horizon Therapeutics was acquired on 06-Oct-2023.

  • Who acquired Horizon Therapeutics?

    Horizon Therapeutics was acquired by Amgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process